BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Pancreas
,
Pharmacogenetics
,
Quercetin
,
rs2230926
,
FXYD4
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Bcr protein
Summary
General Info
Curated Studies
Most Correlated Studies
Progenitor B BaF3 cells with DOX-induced BCR-ABL expression in the presence or absence of IL-3
Differentiation-induced gene expression in IL-7-dependent and BCR-ABL1-transformed pre-B cells
Expression in bone marrow progenitor cells overexprssing BCR-ABL1 and/or AID
Spleens of mice transplanted with stem cells expressing fusion proteins BCR/ABL and ABL/BCR
Gleevec treatment of BCR-ABL positive and negative leukemia cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STA…
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients…
Crystal structure of timothy grass allergen Phl p 12.0101 reveals an unusual profilin dimer.
Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization a…
Functional characterization of two rare BCR-FGFR1+ leukemias.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromos…
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-AB…
Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
Nilotinib in PH+, BCR-, ABL+ CML Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ